Detalles de la búsqueda
1.
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation.
Blood
; 141(23): 2901-2911, 2023 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36940410
2.
Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysis.
Am J Hematol
; 99(5): 844-853, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38357714
3.
Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial.
Haematologica
; 108(11): 3001-3010, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37259567
4.
Acute myeloid leukemia-induced functional inhibition of healthy CD34+ hematopoietic stem and progenitor cells.
Stem Cells
; 39(9): 1270-1284, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34013984
5.
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Ann Hematol
; 100(4): 959-968, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33191481
6.
Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1-mRNA expression in patients with AML and MDS.
Eur J Haematol
; 107(2): 283-292, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33987857
7.
Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous Leukemia.
Biol Blood Marrow Transplant
; 25(8): 1550-1559, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30880268
8.
Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignancies.
Ann Hematol
; 98(5): 1225-1235, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30923997
9.
Spontaneous remission in a patient with very late relapse of acute myeloid leukemia 17 years after allogeneic blood stem cell transplantation.
Eur J Haematol
; 103(2): 131-133, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31066931
10.
Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment.
Int J Mol Sci
; 20(1)2019 Jan 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30626126
11.
Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(11): 2337-2343, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753838
12.
Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Ann Hematol
; 97(2): 335-342, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29151133
13.
Sorafenib and azacitidine as salvage therapy for relapse of FLT3-ITD mutated AML after allo-SCT.
Eur J Haematol
; 98(4): 348-354, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27893163
14.
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Ann Hematol
; 100(8): 2141-2142, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34160650
15.
Influence of somatic mutations and pretransplant strategies in patients allografted for myelodysplastic syndrome or secondary acute myeloid leukemia.
Am J Hematol
; 96(1): E15-E17, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33017477
16.
Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study.
Clin Cancer Res
; 30(9): 1778-1787, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38514469
17.
Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation.
Bone Marrow Transplant
; 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38773281
18.
Allogeneic hematopoietic stem cell transplantation and pre-transplant strategies in patients with NPM1-mutated acute myeloid leukemia: a single center experience.
Sci Rep
; 13(1): 10774, 2023 07 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37402862
19.
Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic Component.
Cancers (Basel)
; 14(24)2022 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36551729
20.
High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative Analysis.
Hemasphere
; 6(10): e784, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36204690